Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus
BBA Clinical · 2015-12 · 4 · 102-107
DOI: 10.1016/j.bbacli.2015.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift BBA Clinical, 2015-12. Verfasst von Gay Carter und 5 weiteren Autor:innen. Beteiligte Einrichtung: James A. Haley Veterans Hospital, Tampa, FL 33612, United States. Die Arbeit wurde bisher 150-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Veterans Affairs Medical Research.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Diabetes mellitus (DM), a metabolic disease, is characterized by impaired fasting glucose levels. Type 2 DM is adult onset diabetes. Long non-coding RNAs (lncRNAs) regulate gene expression and multiple studies have linked lncRNAs to human diseases. METHODS: Serum samples obtained from 96 participating veterans at JAH VA were deposited in the Research Biospecimen Repository. We used a two-stage strategy to identify an lncRNA whose levels correlated with T2DM. Initially we screened five serum samples from diabetic and non-diabetic individuals using lncRNA arrays. Next, GAS5 lncRNA levels were analyzed in 96 serum samples using quantitative PCR. Receiver operating characteristic (ROC) analysis was performed to determine the optimal cutoff GAS5 for diagnosis of DM. RESULTS: Our results demonstrate that decreased GAS5 levels in serum were associated with diabetes in a cohort of US military veterans. The ROC analysis revealed an optimal cutoff GAS5 value of less than or equal to 10. qPCR results indicated that individuals with absolute GAS5 < 10 ng/μl have almost twelve times higher odds of having diabetes (Exact Odds Ratio [OR] = 11.79 (95% CI: 3.97, 37.26), p < 0.001). Analysis indicated area under curve (AUC) of ROC of 0.81 with 85.1% sensitivity and 67.3% specificity in distinguishing non-diabetic from diabetic subjects. The positive predictive value is 71.4%. CONCLUSION: lncRNA GAS5 levels are correlated to prevalence of T2DM. GENERAL SIGNIFICANCE: Assessment of GAS5 in serum along with other parameters offers greater accuracy in identifying individuals at-risk for diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- James A. Haley Veterans Hospital, Tampa, FL 33612, United States.
- University of South Florida, Tampa, FL 33612, United States.
- James A. Haley Veterans Hospital, Tampa, FL 33612, United States ; University of South Florida, Tampa, FL 33612, United States.
Förderung
- Department of Veterans Affairs Medical Research
Zitieren
APA
Carter, G., Miladinovic, B., Patel, A. A., Deland, L., Mastorides, S., & Patel, N. A. (2015). Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clinical, 4, 102-107. https://doi.org/10.1016/j.bbacli.2015.09.001
Vancouver
Carter G, Miladinovic B, Patel AA, Deland L, Mastorides S, Patel NA. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clinical. 2015;4:102-107. doi:10.1016/j.bbacli.2015.09.001
BibTeX
@article{Carter2015,
author = {Carter, Gay and Miladinovic, Branko and Patel, Achintya A and Deland, Lauren and Mastorides, Stephen and Patel, Niketa A},
title = {Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus},
journal = {BBA Clinical},
year = {2015},
volume = {4},
pages = {102--107},
doi = {10.1016/j.bbacli.2015.09.001}
}
EUVIMED